CA2190136C - Method and apparatus for ameliorating aging process - Google Patents

Method and apparatus for ameliorating aging process Download PDF

Info

Publication number: CA2190136C
Authority: CA; Canada
Prior art keywords: mass; targets; fields; target; gauss
Prior art date: 1994-05-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2190136A

Other languages

English (en)

French (fr)

Other versions

CA2190136A1 (en

Inventor

Jerry Jacobson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-25

Filing date

1995-05-25

Publication date

2011-05-24

1995-05-24 Priority claimed from US08/440,896 external-priority patent/US6004257A/en

1995-05-25 Application filed by Individual filed Critical Individual

1995-11-30 Publication of CA2190136A1 publication Critical patent/CA2190136A1/en

2011-05-24 Application granted granted Critical

2011-05-24 Publication of CA2190136C publication Critical patent/CA2190136C/en

2015-05-25 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

230000032683 aging Effects 0.000 title claims abstract description 29
238000000034 method Methods 0.000 title abstract description 18
230000004907 flux Effects 0.000 claims abstract description 74
238000011282 treatment Methods 0.000 claims abstract description 42
230000000694 effects Effects 0.000 claims abstract description 34
108090000623 proteins and genes Proteins 0.000 claims description 51
102000004169 proteins and genes Human genes 0.000 claims description 28
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
230000005672 electromagnetic field Effects 0.000 claims description 22
108700005087 Homeobox Genes Proteins 0.000 claims description 15
230000006870 function Effects 0.000 claims description 14
108700020796 Oncogene Proteins 0.000 claims description 13
108010025020 Nerve Growth Factor Proteins 0.000 claims description 12
102000015336 Nerve Growth Factor Human genes 0.000 claims description 11
239000011575 calcium Substances 0.000 claims description 11
229910052751 metal Inorganic materials 0.000 claims description 11
239000002184 metal Substances 0.000 claims description 11
150000002739 metals Chemical class 0.000 claims description 10
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
102000043276 Oncogene Human genes 0.000 claims description 9
229910052791 calcium Inorganic materials 0.000 claims description 9
230000008685 targeting Effects 0.000 claims description 8
230000008859 change Effects 0.000 claims description 7
230000007423 decrease Effects 0.000 claims description 7
230000003467 diminishing effect Effects 0.000 claims description 7
230000001228 trophic effect Effects 0.000 claims description 7
108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 5
102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 5
-1 calcium Chemical class 0.000 claims description 5
229940053128 nerve growth factor Drugs 0.000 claims description 5
230000003247 decreasing effect Effects 0.000 claims description 3
230000002255 enzymatic effect Effects 0.000 claims description 3
239000000813 peptide hormone Substances 0.000 claims description 3
102000003886 Glycoproteins Human genes 0.000 claims description 2
108090000288 Glycoproteins Proteins 0.000 claims description 2
102000014150 Interferons Human genes 0.000 claims description 2
108010050904 Interferons Proteins 0.000 claims description 2
102000015696 Interleukins Human genes 0.000 claims description 2
108010063738 Interleukins Proteins 0.000 claims description 2
102000004895 Lipoproteins Human genes 0.000 claims description 2
108090001030 Lipoproteins Proteins 0.000 claims description 2
101710172711 Structural protein Proteins 0.000 claims description 2
229940079322 interferon Drugs 0.000 claims description 2
229940047122 interleukins Drugs 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims 4
102000007072 Nerve Growth Factors Human genes 0.000 claims 1
238000004364 calculation method Methods 0.000 abstract description 8
230000036541 health Effects 0.000 abstract description 5
210000004027 cell Anatomy 0.000 description 28
230000003993 interaction Effects 0.000 description 26
230000001413 cellular effect Effects 0.000 description 23
108020004414 DNA Proteins 0.000 description 20
108090000790 Enzymes Proteins 0.000 description 19
102000004190 Enzymes Human genes 0.000 description 19
230000033001 locomotion Effects 0.000 description 15
150000002500 ions Chemical class 0.000 description 13
230000001225 therapeutic effect Effects 0.000 description 13
230000003612 virological effect Effects 0.000 description 13
241000700605 Viruses Species 0.000 description 12
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
230000005358 geomagnetic field Effects 0.000 description 12
239000002858 neurotransmitter agent Substances 0.000 description 11
239000002245 particle Substances 0.000 description 11
201000010099 disease Diseases 0.000 description 10
230000014509 gene expression Effects 0.000 description 10
230000002068 genetic effect Effects 0.000 description 10
230000005484 gravity Effects 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
238000012546 transfer Methods 0.000 description 10
230000001965 increasing effect Effects 0.000 description 9
230000009182 swimming Effects 0.000 description 9
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 8
229940088597 hormone Drugs 0.000 description 8
239000005556 hormone Substances 0.000 description 8
229960003987 melatonin Drugs 0.000 description 8
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 8
230000003292 diminished effect Effects 0.000 description 7
230000010355 oscillation Effects 0.000 description 6
230000008569 process Effects 0.000 description 6
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 5
210000004556 brain Anatomy 0.000 description 5
230000012010 growth Effects 0.000 description 5
239000001257 hydrogen Substances 0.000 description 5
229910052739 hydrogen Inorganic materials 0.000 description 5
230000006872 improvement Effects 0.000 description 5
230000002269 spontaneous effect Effects 0.000 description 5
238000013518 transcription Methods 0.000 description 5
230000035897 transcription Effects 0.000 description 5
108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
230000003321 amplification Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
239000000470 constituent Substances 0.000 description 4
230000005489 elastic deformation Effects 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
229910021645 metal ion Inorganic materials 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
230000029058 respiratory gaseous exchange Effects 0.000 description 4
231100000241 scar Toxicity 0.000 description 4
230000035882 stress Effects 0.000 description 4
230000005481 string theory Effects 0.000 description 4
241000196324 Embryophyta Species 0.000 description 3
230000005355 Hall effect Effects 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
230000001668 ameliorated effect Effects 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
230000017531 blood circulation Effects 0.000 description 3
210000000988 bone and bone Anatomy 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
239000004020 conductor Substances 0.000 description 3
238000004132 cross linking Methods 0.000 description 3
238000009826 distribution Methods 0.000 description 3
230000005670 electromagnetic radiation Effects 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
230000004927 fusion Effects 0.000 description 3
229910052732 germanium Inorganic materials 0.000 description 3
GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
229940072221 immunoglobulins Drugs 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
239000002773 nucleotide Substances 0.000 description 3
125000003729 nucleotide group Chemical group 0.000 description 3
201000008482 osteoarthritis Diseases 0.000 description 3
238000001953 recrystallisation Methods 0.000 description 3
230000035939 shock Effects 0.000 description 3
230000019491 signal transduction Effects 0.000 description 3
241000894007 species Species 0.000 description 3
230000014616 translation Effects 0.000 description 3
UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
229930182837 (R)-adrenaline Natural products 0.000 description 2
208000030507 AIDS Diseases 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
102000002812 Heat-Shock Proteins Human genes 0.000 description 2
108010004889 Heat-Shock Proteins Proteins 0.000 description 2
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
102000011782 Keratins Human genes 0.000 description 2
108010076876 Keratins Proteins 0.000 description 2
101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 2
108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 2
108700005075 Regulator Genes Proteins 0.000 description 2
206010041591 Spinal osteoarthritis Diseases 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
238000005147 X-ray Weissenberg Methods 0.000 description 2
238000013019 agitation Methods 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
230000001363 autoimmune Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000002051 biphasic effect Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
230000003915 cell function Effects 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
238000004891 communication Methods 0.000 description 2
230000006835 compression Effects 0.000 description 2
238000007906 compression Methods 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000002542 deteriorative effect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000010586 diagram Methods 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
229960005139 epinephrine Drugs 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
230000003203 everyday effect Effects 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000005283 ground state Effects 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
231100001261 hazardous Toxicity 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
239000012535 impurity Substances 0.000 description 2
230000005381 magnetic domain Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
230000003387 muscular Effects 0.000 description 2
230000035772 mutation Effects 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
210000004940 nucleus Anatomy 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
210000005259 peripheral blood Anatomy 0.000 description 2
239000011886 peripheral blood Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
238000001243 protein synthesis Methods 0.000 description 2
230000005855 radiation Effects 0.000 description 2
230000008929 regeneration Effects 0.000 description 2
238000011069 regeneration method Methods 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
239000013535 sea water Substances 0.000 description 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
210000002435 tendon Anatomy 0.000 description 2
238000010361 transduction Methods 0.000 description 2
230000026683 transduction Effects 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
101150094765 70 gene Proteins 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
208000007848 Alcoholism Diseases 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
241000380131 Ammophila arenaria Species 0.000 description 1
101710145634 Antigen 1 Proteins 0.000 description 1
206010003210 Arteriosclerosis Diseases 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
208000020084 Bone disease Diseases 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
206010007269 Carcinogenicity Diseases 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
206010010305 Confusional state Diseases 0.000 description 1
102000010970 Connexin Human genes 0.000 description 1
108050001175 Connexin Proteins 0.000 description 1
206010056340 Diabetic ulcer Diseases 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
208000027534 Emotional disease Diseases 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
206010063560 Excessive granulation tissue Diseases 0.000 description 1
206010017085 Fracture malunion Diseases 0.000 description 1
208000010412 Glaucoma Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
101710103773 Histone H2B Proteins 0.000 description 1
102100021639 Histone H2B type 1-K Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
208000012659 Joint disease Diseases 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
208000019695 Migraine disease Diseases 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
102000029797 Prion Human genes 0.000 description 1
108091000054 Prion Proteins 0.000 description 1
102000003923 Protein Kinase C Human genes 0.000 description 1
108090000315 Protein Kinase C Proteins 0.000 description 1
102000009092 Proto-Oncogene Proteins c-myc Human genes 0.000 description 1
108010087705 Proto-Oncogene Proteins c-myc Proteins 0.000 description 1
239000013614 RNA sample Substances 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
206010063562 Radiation skin injury Diseases 0.000 description 1
206010038743 Restlessness Diseases 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
208000008765 Sciatica Diseases 0.000 description 1
229920006328 Styrofoam Polymers 0.000 description 1
206010047139 Vasoconstriction Diseases 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
231100000569 acute exposure Toxicity 0.000 description 1
108060000200 adenylate cyclase Proteins 0.000 description 1
102000030621 adenylate cyclase Human genes 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
230000036626 alertness Effects 0.000 description 1
230000004075 alteration Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
206010002022 amyloidosis Diseases 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
208000011775 arteriosclerosis disease Diseases 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
238000010009 beating Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
230000003185 calcium uptake Effects 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
231100000315 carcinogenic Toxicity 0.000 description 1
231100000260 carcinogenicity Toxicity 0.000 description 1
230000007670 carcinogenicity Effects 0.000 description 1
206010061592 cardiac fibrillation Diseases 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
230000009084 cardiovascular function Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000025084 cell cycle arrest Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000009087 cell motility Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
208000036319 cervical spondylosis Diseases 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
201000002797 childhood leukemia Diseases 0.000 description 1
208000011654 childhood malignant neoplasm Diseases 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
231100000244 chromosomal damage Toxicity 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000003280 chronobiological effect Effects 0.000 description 1
230000002060 circadian Effects 0.000 description 1
230000007012 clinical effect Effects 0.000 description 1
230000003920 cognitive function Effects 0.000 description 1
230000001427 coherent effect Effects 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
210000000877 corpus callosum Anatomy 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000003436 cytoskeletal effect Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000008260 defense mechanism Effects 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
230000003831 deregulation Effects 0.000 description 1
238000009795 derivation Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
230000005674 electromagnetic induction Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000001973 epigenetic effect Effects 0.000 description 1
230000001037 epileptic effect Effects 0.000 description 1
230000005284 excitation Effects 0.000 description 1
230000006832 extrinsic signaling Effects 0.000 description 1
230000002600 fibrillogenic effect Effects 0.000 description 1
238000005188 flotation Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
229960003692 gamma aminobutyric acid Drugs 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
210000003976 gap junction Anatomy 0.000 description 1
239000007789 gas Substances 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
239000008103 glucose Substances 0.000 description 1
210000001126 granulation tissue Anatomy 0.000 description 1
238000009499 grossing Methods 0.000 description 1
230000003779 hair growth Effects 0.000 description 1
208000024963 hair loss Diseases 0.000 description 1
230000003676 hair loss Effects 0.000 description 1
230000035876 healing Effects 0.000 description 1
229960001340 histamine Drugs 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000036737 immune function Effects 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000035992 intercellular communication Effects 0.000 description 1
201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000005304 joining Methods 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000000696 magnetic material Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
206010027599 migraine Diseases 0.000 description 1
210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
229910000595 mu-metal Inorganic materials 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
231100000804 nongenotoxic Toxicity 0.000 description 1
238000009377 nuclear transmutation Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
230000006548 oncogenic transformation Effects 0.000 description 1
210000004789 organ system Anatomy 0.000 description 1
239000005416 organic matter Substances 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
230000033116 oxidation-reduction process Effects 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000013618 particulate matter Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000008447 perception Effects 0.000 description 1
230000024159 perception of rate of movement Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
208000024335 physical disease Diseases 0.000 description 1
239000000049 pigment Substances 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000005656 quantum gravity Effects 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
230000033764 rhythmic process Effects 0.000 description 1
230000001020 rhythmical effect Effects 0.000 description 1
239000000523 sample Substances 0.000 description 1
230000035807 sensation Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
229940076279 serotonin Drugs 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
208000005801 spondylosis Diseases 0.000 description 1
230000037351 starvation Effects 0.000 description 1
230000003068 static effect Effects 0.000 description 1
239000008261 styrofoam Substances 0.000 description 1
230000002889 sympathetic effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000008736 traumatic injury Effects 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000025033 vasoconstriction Effects 0.000 description 1
230000024883 vasodilation Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Magnetic Treatment Devices (AREA)
Electrotherapy Devices (AREA)

CA2190136A 1994-05-25 1995-05-25 Method and apparatus for ameliorating aging process Expired - Fee Related CA2190136C (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US24924494A	1994-05-25	1994-05-25
US08/249,244		1994-05-25
US08/440,896 US6004257A (en)	1994-05-25	1995-05-24	Method for ameliorating the aging process and the effects thereof utilizing electromagnetic energy
US08/440,896		1995-05-24
PCT/US1995/006417 WO1995031939A1 (en)	1994-05-25	1995-05-25	Method and apparatus for ameliorating aging process

Publications (2)

Publication Number	Publication Date
CA2190136A1 CA2190136A1 (en)	1995-11-30
CA2190136C true CA2190136C (en)	2011-05-24

Family

ID=26939922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2190136A Expired - Fee Related CA2190136C (en)	1994-05-25	1995-05-25	Method and apparatus for ameliorating aging process

Country Status (7)

Country	Link
EP (1)	EP0762852A4 (de)
JP (1)	JPH10500872A (de)
CN (1)	CN1151685A (de)
AU (1)	AU2690695A (de)
CA (1)	CA2190136C (de)
MX (1)	MX9605799A (de)
WO (1)	WO1995031939A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT240996Y1 (it) *	1996-11-07	2001-04-20	Kalor Thermotechnik G M B H	Vasca da bagno ad azione magnetoterapica
US5968527A (en) *	1997-02-27	1999-10-19	Catholic University Of America, The	Protection of living systems from the adverse effects of stress
US6458071B1 (en) *	1997-12-08	2002-10-01	Jerry I. Jacobson	Method for electromagnetically restructuring water for organismic consumption
US7186209B2 (en)	2003-10-09	2007-03-06	Jacobson Jerry I	Cardioelectromagnetic treatment
US8613695B2 (en)	2008-07-10	2013-12-24	Applied Magnetics, Llc	Highly precise and low level signal-generating drivers, systems, and methods of use
CN102186538B (zh)	2008-08-25	2016-11-16	应用磁学有限责任公司	用于向对象提供磁共振治疗的系统和方法
WO2015006831A1 (en) *	2013-07-17	2015-01-22	Hts Therapeutics Pty Ltd	A method for reducing, inflammation, coagulation and adhesions
IT202100015971A1 (it) *	2021-06-18	2022-12-18	Non Ionizing Radiation Personal Shielding S R L	Dispositivo retroazionato per la ionorisonanza ciclotronica

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US781448A (en)	1904-10-29	1905-01-31	John Mcintyre	Electromagnetic apparatus.
US2103440A (en)	1932-07-15	1937-12-28	Weissenberg Eugen	Electrotherapeutic apparatus
US2099511A (en)	1933-03-16	1937-11-16	Caesar Viktor	Oscillator for the biological treatment of living tissue
AT316729B (de)	1971-04-06	1974-07-25	Kraus Werner	Gerät zur Unterstützung der Bildung von Knochensubstanz
US3738369A (en)	1971-04-22	1973-06-12	Gen Electric	Body organ stimulator function control switch
DE3376163D1 (en)	1982-05-26	1988-05-05	Richard Hugh Cameron Bentall	Electrical therapy apparatus
US5269746A (en)	1982-12-20	1993-12-14	Jacobson Jerry I	Therapeutic treatment of mammals for epilepsy and Parkinson's disease
GB8316377D0 (en)	1983-06-16	1983-07-20	Bentall R H C	Electrical therapy apparatus
CA2004192A1 (en) *	1988-11-30	1990-05-31	Jerry I. Jacobson	Therapeutic treatment of mammals

1995
- 1995-05-25 WO PCT/US1995/006417 patent/WO1995031939A1/en not_active Ceased
- 1995-05-25 CA CA2190136A patent/CA2190136C/en not_active Expired - Fee Related
- 1995-05-25 EP EP95922099A patent/EP0762852A4/de not_active Ceased
- 1995-05-25 CN CN 95193839 patent/CN1151685A/zh active Pending
- 1995-05-25 AU AU26906/95A patent/AU2690695A/en not_active Abandoned
- 1995-05-25 MX MX9605799A patent/MX9605799A/es unknown
- 1995-05-25 JP JP7530468A patent/JPH10500872A/ja not_active Ceased

Also Published As

Publication number	Publication date
CA2190136A1 (en)	1995-11-30
EP0762852A1 (de)	1997-03-19
AU2690695A (en)	1995-12-18
EP0762852A4 (de)	2000-03-08
JPH10500872A (ja)	1998-01-27
WO1995031939A1 (en)	1995-11-30
MX9605799A (es)	1997-12-31
CN1151685A (zh)	1997-06-11

Legal Events

Date	Code	Title	Description
2002-05-15	EEER	Examination request
2015-07-06	MKLA	Lapsed	Effective date: 20150525

Publication	Publication Date	Title
US6004257A (en)	1999-12-21	Method for ameliorating the aging process and the effects thereof utilizing electromagnetic energy
US6733434B2 (en)	2004-05-11	Method and apparatus for electromagnetically restructuring ingestible substances for organismic consumption
US6458071B1 (en)	2002-10-01	Method for electromagnetically restructuring water for organismic consumption
Blank	1995	Biological effects of environmental electromagnetic fields: molecular mechanisms
Rosch	2009	Bioelectromagnetic and subtle energy medicine: the interface between mind and matter
CA2190136C (en)	2011-05-24	Method and apparatus for ameliorating aging process
JP2917034B2 (ja)	1999-07-12	治療処置装置
KR101603723B1 (ko)	2016-03-15	미세전류 침대
Jacobson	1991	A look at the possible mechanism and potential of magneto therapy
Saxena et al.	2003	A hypothetical mathematical construct explaining the mechanism of biological amplification in an experimental model utilizing picoTesla (PT) electromagnetic fields
Sandurkov et al.	2023	Low energy magnetic stimulation of the phrenic nerve-a simulation study
Yuan et al.	2017	Theoretical analysis of the effects of transcranial magneto-acoustical stimulation on neuronal firing rhythm and Ca2+ concentration with Chay neuron model
Ebrahimi et al.	2015	An introduction to impact of bio-resonance technology in genetics and epigenetics
Jacobson et al.	2015	Aging and magnetism: Presenting a possible new holistic paradigm for ameliorating the aging process and the effects thereof, through externally applied physiologic PicoTesla magnetic fields
Sidorov et al.	2012	Biophysical Mechanisms of Genetic Regulation: Is There a Link to Mind-Body Healing?
Vodovnik et al.	1995	A theoretical approach to perturbation of biological systems by electrical currents
JP3200432U (ja)	2015-10-22	電位変動型量子治療器
Hörning et al.	2010	Utilizing the eikonal relationship in strategies for reentrant wave termination in excitable media
Shigemitsu et al.	2022	The History of Bioelectromagnetism
Barnes	2018	Interaction of static and extremely low-frequency electric fields with biological materials and systems
Markov et al.	2005	Systemic effect: a new approach to magnetic field therapy
Zoofaghari et al.	2026	Electrophoretic beam steering in molecular communication: Toward targeted extracellular vesicle delivery
Bunnell	1997	A tentative mechanism for healing
CN107802962A (zh)	2018-03-16	一种磁疗贴
Barassi et al.	2026	Advances in Bioresonance therapy